Comparing Cytoreductive Nephrectomy with Tumor Thrombectomy Between Open, Laparoscopic, and Robotic Approaches
Maxwell Sandberg, Gregory B. Russell, Mitchell Hayes, Randall Bissette, Reuben Ben‐David, Kartik R. Patel, Brejjette Aljabi, Seok‐Soo Byun, Ó. Rodríguez Faba, Patricio García Marchiñena, Thiago Camelo Mourão, Gaetano Ciancio, Charles C. Peyton, Rafael Ribeiro Zanotti, Philippe E. Spiess, Reza Mehrazin, Soroush Rais‐Bahrami, Diego Abreu, Stênio de Cássio Zéqui, Alejandro Rodríguez
- 发表年份
- 2025
- 引用次数
- 2
- 访问权限
- 开放获取
摘要
Background/Objectives: For surgical candidates with metastatic renal cell carcinoma with a tumor thrombus (mRCC-TT), surgery is cytoreductive nephrectomy with tumor thrombectomy (CN-TT). This is carried out through an open (OCN-TT), laparoscopic (LCN-TT), or robotic (RCN-TT) approach. The purpose of this study was to compare survival outcomes to CN-TT by operative approach. Methods: This was a retrospective analysis of all patients with a diagnosis of mRCC-TT, who underwent CN-TT from a multi-institutional database from 1999–2024. Metastatic locations were qualified as either lung, bone, brain, liver, retroperitoneum, adrenal, paraaortic nodes, or other nodes. Progression was defined as radiographic evidence of recurrence or metastasis not seen on imaging prior to CN-TT. Progression locations were all metastatic locales previously noted plus the nephrectomy bed. Overall survival (OS), cancer-specific survival (CSS), and progression-free survival (PFS) were calculated. Comparisons were performed between OCN-TT, LCN-TT, and RCN-TT. Results: A total of 131 patients were included in the analysis (97 OCN-TT, 25 LCN-TT, and 9 RCN-TT). The TT level was not different (p-value > 0.05) by approach (p-value > 0.05). Preoperative tumor size, final pathologic tumor subtype, and postoperative tumor size were equivalent between the three surgical approaches (p-value > 0.05). Rates of progression were equivalent as were all locations of disease progression in the study (p-value > 0.05). Median OS was 1.6 years in OCN-TT, 1.5 years in LCN-TT, and 2.5 years in RCN-TT (p-value = 0.42). Median CSS was 2.1 years in OCN-TT, 3 years in LCN-TT, and 2.5 years in RCN-TT (p-value = 0.86). PFS was 0.8 years in OCN-TT, 1.2 years in LCN-TT, and 1.2 years in RNC-TT (p-value = 0.76). Conclusions: The operative approach does not affect survival outcomes for CN-TT. Surgeon comfort and patient preference should weigh heavily in operative decision making.
关键词
相关论文
Campbell-Walsh urology
Alan J. Wein editor-in-chief
2012
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Bernard Escudier, Camillo Porta, Manuela Schmidinger 等 8 位作者
2014
Principles of Robot Motion: Theory, Algorithms, and Implementations
Howie Choset, Jean‐Claude Latombe
2005
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
Pedro T. Ramírez, Michael Frumovitz, René Pareja 等 19 位作者
2018